JP2013542204A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542204A5
JP2013542204A5 JP2013532015A JP2013532015A JP2013542204A5 JP 2013542204 A5 JP2013542204 A5 JP 2013542204A5 JP 2013532015 A JP2013532015 A JP 2013532015A JP 2013532015 A JP2013532015 A JP 2013532015A JP 2013542204 A5 JP2013542204 A5 JP 2013542204A5
Authority
JP
Japan
Prior art keywords
ethylcarbamoylamino
benzothiazol
pyrimidin
piperidine
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013532015A
Other languages
English (en)
Japanese (ja)
Other versions
JP5864589B2 (ja
JP2013542204A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2011/001284 external-priority patent/WO2012045124A1/en
Publication of JP2013542204A publication Critical patent/JP2013542204A/ja
Publication of JP2013542204A5 publication Critical patent/JP2013542204A5/ja
Application granted granted Critical
Publication of JP5864589B2 publication Critical patent/JP5864589B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013532015A 2010-10-08 2011-10-07 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類 Expired - Fee Related JP5864589B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39116310P 2010-10-08 2010-10-08
US61/391,163 2010-10-08
PCT/AU2011/001284 WO2012045124A1 (en) 2010-10-08 2011-10-07 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls

Publications (3)

Publication Number Publication Date
JP2013542204A JP2013542204A (ja) 2013-11-21
JP2013542204A5 true JP2013542204A5 (enExample) 2014-11-27
JP5864589B2 JP5864589B2 (ja) 2016-02-17

Family

ID=45925612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013532015A Expired - Fee Related JP5864589B2 (ja) 2010-10-08 2011-10-07 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類

Country Status (6)

Country Link
US (1) US9181234B2 (enExample)
EP (1) EP2625178A4 (enExample)
JP (1) JP5864589B2 (enExample)
CN (1) CN103249732B (enExample)
AU (1) AU2011313820A1 (enExample)
WO (1) WO2012045124A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6085829B2 (ja) 2011-01-14 2017-03-01 スペロ トリネム, インコーポレイテッド ピリミジンジャイレースおよびトポイソメラーゼiv阻害剤
MX341342B (es) 2011-01-14 2016-08-17 Vertex Pharma Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea.
US8481552B2 (en) 2011-01-14 2013-07-09 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea
KR101882172B1 (ko) 2011-01-14 2018-07-26 스페로 트리넴, 인코포레이티드 자이라제 및 토포이소머라제 ⅳ 억제제의 제조방법
ES2576298T3 (es) 2011-06-20 2016-07-06 Vertex Pharmaceuticals Incorporated Ésteres de fosfato de inhibidores de girasa y topoisomerasa
HK1206031A1 (en) 2012-03-22 2015-12-31 生物区欧洲有限公司 Antibacterial compounds
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
US9018216B2 (en) 2012-07-18 2015-04-28 Vertex Pharmaceuticals Incorporated Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
SG11201606332PA (en) 2014-02-03 2016-09-29 Spero Gyrase Inc Antibacterial combinations comprising polymyxin
CN104230991A (zh) * 2014-08-25 2014-12-24 亿腾药业(泰州)有限公司 一种控制福沙吡坦二甲葡胺中钯残留的方法
WO2016119700A1 (en) * 2015-01-28 2016-08-04 Jn Therapeutics Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
CN106167486B (zh) * 2015-05-22 2019-06-14 北京四环制药有限公司 单环类回旋酶和拓扑异构酶iv抑制剂
TWI828027B (zh) 2016-03-28 2024-01-01 美商英塞特公司 作為tam抑制劑之吡咯并三嗪化合物
JP6888101B2 (ja) * 2017-01-18 2021-06-16 アレイ バイオファーマ インコーポレイテッド RETキナーゼ阻害剤としての置換ピラゾロ[1,5−a]ピラジン化合物
RU2019133662A (ru) 2017-03-24 2021-04-26 Тайсо Фармасьютикал Ко., Лтд. Производное 2(1h)-хинолинона
WO2019057946A1 (en) 2017-09-25 2019-03-28 F. Hoffmann-La Roche Ag MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS
WO2019126731A1 (en) 2017-12-22 2019-06-27 Petra Pharma Corporation Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
TW202112767A (zh) 2019-06-17 2021-04-01 美商佩特拉製藥公司 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
BR112022002815A2 (pt) * 2019-08-15 2022-05-10 Bayer Ag Método para preparar 2-(fenilimino)-3-alquil-1,3-tiazolidin- 4-onas
CN115315425B (zh) * 2020-08-14 2025-03-28 上海复旦张江生物医药股份有限公司 一种取代的咪唑并[1,2-a]吡啶-2-基酰胺化合物的制备方法及其中间体
CN115073358B (zh) * 2022-07-21 2023-09-26 安徽德诺医药股份有限公司 一种n-苄基-4-哌啶甲酸乙酯的制备方法
CN118955404B (zh) * 2024-07-30 2026-06-12 凯美克(上海)医药科技有限公司 一种化合物3,5-二溴哒嗪的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
PL362691A1 (en) * 2000-12-15 2004-11-02 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
US8404852B2 (en) * 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7569591B2 (en) * 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7618974B2 (en) * 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US20090281097A1 (en) * 2006-04-14 2009-11-12 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
EP2321309A1 (en) * 2008-06-25 2011-05-18 Ranbaxy Laboratories Limited Benzothiazoles and aza-analogues thereof use as antibacterial agents
WO2010100144A1 (en) * 2009-03-04 2010-09-10 Merck Serono S.A. Fused bicyclic compounds as inhibitors for pi3 kinase

Similar Documents

Publication Publication Date Title
RU2012130436A (ru) Новое антитромботическое средство
JP2013508404A5 (enExample)
JP2020514267A5 (enExample)
JP5864589B2 (ja) 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類
JP2018536671A5 (enExample)
RU2012136643A (ru) [5,6]- гетероциклическое соединение
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2013523884A5 (enExample)
RU2012105284A (ru) Спиро-аминосоединения, пригодные для лечения нарушений сна и лекарственного привыкания
JP2018507235A5 (enExample)
JP2016520116A5 (enExample)
JP2012501312A5 (enExample)
JP2011506417A5 (enExample)
JP2015517566A5 (enExample)
JP2016500073A5 (enExample)
JP2015522002A5 (enExample)
RU2019116251A (ru) Пиразоло[3,4-b]пиридины и имидазо[1,5-b]пиридазины в качестве ингибиторов pde1
JP2017535561A5 (enExample)
RU2009142851A (ru) Ингибиторы киназы, пригодные для лечения миелопролиферативных заболеваний и других пролиферативных заболеваний
JP2016514718A5 (enExample)
JP2013522354A5 (enExample)
JP2016537384A5 (enExample)
JP2017510576A5 (enExample)
JP2011522866A5 (enExample)
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения